5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
Details for Australian Patent Application No. 2004268050 (hide)
International Classifications
Event Publications
9 February 2006 PCT application entered the National Phase
PCT publication WO2005/021519 Priority application(s): WO2005/021519
16 November 2006 Application Accepted
Published as AU-B-2004268050
15 March 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004268051-Process for the purification of terbinafine
2004268042-Flame retardant polymer composition comprising fine particles
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser